Swiss Life Asset Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$114K Buy
13,407
+1,335
+11% +$8.88K ﹤0.01% 1582
2026
Q1
$65.8K Buy
+12,072
New +$67.7K ﹤0.01% 1478
2022
Q3
Sell
-10,006
Closed -$333K 634
2022
Q2
$333K Sell
10,006
-9,516
-49% -$404K 0.01% 556
2022
Q1
$1.41M Buy
+19,522
New +$1.41M 0.02% 448
2021
Q4
Sell
-7,479
Closed -$948K 569
2021
Q3
$948K Buy
7,479
+1,285
+21% +$187K 0.01% 463
2021
Q2
$2.14M Buy
+6,194
New +$1M 0.02% 430

Other funds holding TDOC

Swiss Life Asset Management's TDOC Position: Q2 2026 in Review

Swiss Life Asset Management increased its Teladoc Health (TDOC) stake by 11% in Q2 2026, buying an estimated $8.88K and bringing the position to 13,407 shares worth $114K. The position accounts for ﹤0.01% of the portfolio, ranked #1582.

Swiss Life Asset Management first reported a position in TDOC in Q2 2021 and has held it in 6 quarters since. The position peaked at $2.14M in Q2 2021. 206 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Swiss Life Asset Management held 13,407 shares of Teladoc Health worth $114K as of Q2 2026.
  • Swiss Life Asset Management bought 1,335 Teladoc Health shares in Q2 2026, an estimated $8.88K.
  • Teladoc Health made up ﹤0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #1582 holding.
  • Swiss Life Asset Management first reported a position in Teladoc Health in Q2 2021 and has held it in 6 quarters since.
  • Swiss Life Asset Management's Teladoc Health position peaked at $2.14M in Q2 2021.
  • 206 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.